Keywords: ares-serono, gains, rights, curosurf, swiss, pharmaceutical, group

ARES-SERONO GAINS RIGHTS TO CUROSURF

Article | 06 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Curosurf

Poractant Alfa

Go to drug listing